Status:
COMPLETED
Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL
Lead Sponsor:
Alcon Research
Conditions:
Cataracts
Eligibility:
All Genders
50-75 years
Phase:
PHASE4
Brief Summary
The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).
Eligibility Criteria
Inclusion
- Bilateral cataract patients who require natural crystalline lens removal and bilateral Intraocular Lens (IOL) implantation.
- 50\~75 years of age
- \<1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry readings.
Exclusion
- Patients with pre-existing conditions that could skew the results.
- Any of conditions before and during surgery specified in the product information.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00818116
Start Date
December 1 2008
Last Update
July 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134